Lance Alstodt - Dec 23, 2022 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Signature
/s/ Lance Alstodt
Stock symbol
BRTX
Transactions as of
Dec 23, 2022
Transactions value $
$903
Form type
4
Date filed
12/28/2022, 07:22 AM
Previous filing
Dec 7, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $604 +200 +0.11% $3.02 186K Dec 23, 2022 Direct F1
transaction BRTX Common Stock Purchase $299 +100 +0.05% $2.99 186K Dec 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Stock Option 293K Dec 23, 2022 Common Stock 293K $5.08 Direct F2
holding BRTX Stock Option 42.1K Dec 23, 2022 Common Stock 42.1K $5.08 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
F2 The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
F3 The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.